Tennessee Oncology - GALLATIN - SCRI - PPDS — Gallatin, Tennessee

Tennessee Oncology - GALLATIN - SCRI - PPDS is a clinical research site located in Gallatin, Tennessee, United States 37066.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology - GALLATIN - SCRI - PPDS has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology - GALLATIN - SCRI - PPDS?

Tennessee Oncology - GALLATIN - SCRI - PPDS has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology - GALLATIN - SCRI - PPDS conducted?

Tennessee Oncology - GALLATIN - SCRI - PPDS has 1 clinical trials on record. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Is Tennessee Oncology - GALLATIN - SCRI - PPDS accredited by Crixeo Health?

Tennessee Oncology - GALLATIN - SCRI - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology - GALLATIN - SCRI - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.